Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Consolidative radiation in the management of relapsed/refractory Hodgkin lymphoma: a single institution study.
Journal: Radiation oncology (London, England)
Published: December 23, 2025
Predictive Value of Multiparametric Magnetic Resonance Imaging in Risk Group Stratification of Prostate Adenocarcinoma.
Journal: Advances in radiation oncology
Published: December 15, 2023
COX inhibitor use during definitive radiotherapy is associated with worse hearing preservation in patients with vestibular schwannoma.
Journal: Journal of neuro-oncology
Published: July 19, 2023
Phase I/II study to evaluate consolidative hypofractionated radiation therapy for boosting the residual primary disease in combination with durvalumab after definitive chemoradiation therapy for stage III non-small cell lung cancer (NSCLC): study protocol for a prospective trial.
Journal: Journal of thoracic disease
Published: February 28, 2023
Positive margins matter regardless of subsequent resection findings.
Journal: Oral oncology
Published: January 27, 2022
Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer.
Journal: Annals of translational medicine
Published: March 12, 2021
Extraocular Muscle Enlargement in Growth Hormone-Secreting Pituitary Adenomas.
Journal: AJNR. American journal of neuroradiology
Published: December 11, 2020
Consolidative Radiotherapy After Autologous Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 28, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026